PulseAugur
EN
LIVE 12:25:30
ENTITY Novartis

Novartis

PulseAugur coverage of Novartis — every cluster mentioning Novartis across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
7
7 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D

2 day(s) with sentiment data

RECENT · PAGE 1/1 · 7 TOTAL
  1. TOOL · CL_85784 ·

    Google DeepMind spinoff Isomorphic Labs advances AI drug discovery

    Isomorphic Labs, a Google DeepMind spinoff, is advancing AI-driven drug discovery by developing new computational systems. Their Isomorphic Drug Design Engine (IsoDDE) builds upon AlphaFold's protein structure predictio…

  2. RESEARCH · CL_83657 ·

    SpaceX eyes healthcare with Starlink, orbital drug manufacturing, and AI

    SpaceX is exploring multiple avenues into the healthcare sector, leveraging its Starlink satellite internet service to improve remote healthcare access in underserved regions. The company also plans to manufacture pharm…

  3. RESEARCH · CL_55159 ·

    Sanofi builds internal AI ecosystem, eschewing third-party tools

    Sanofi is developing its own AI ecosystem, moving away from licensing third-party tools like ChatGPT and Copilot. The company has launched an internal generative AI assistant called Concierge, now used by 80% of its wor…

  4. RESEARCH · CL_54533 ·

    Demis Hassabis' Isomorphic Labs raises $2.1B for AI drug discovery

    Isomorphic Labs, an AI drug discovery startup founded by Demis Hassabis, has secured $2.1 billion in Series B funding led by Thrive Capital. The company plans to use the new capital to scale its compute resources, gener…

  5. SIGNIFICANT · CL_42344 ·

    Kordata Dynamics launches neurotech platform for clinical trials

    Kordata Dynamics has launched to address a $26 billion market in central nervous system (CNS) therapeutics by integrating neurotechnology into clinical trials. The company, a spinout from BIOS Health, will partner with …

  6. SIGNIFICANT · CL_04864 ·

    Anthropic adds Novartis CEO Vas Narasimhan to Board of Directors

    Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis, to its Board of Directors. Narasimhan's extensive experience in developing and approving new medicines in a highly regulated industry is…

  7. SIGNIFICANT · CL_04616 ·

    Google DeepMind spinoff Isomorphic Labs raises $2.1B for AI drug trials

    Isomorphic Labs, an AI-driven drug discovery company spun out of Google DeepMind, has secured over $2 billion in a Series B funding round. The substantial investment, led by Thrive Capital, will be used to expand its pr…